Cognitive and behavioural impairment in Parkinson's disease

References

• Aarsland D, Andersen K, Larsen JP, Lolk A, Kragh-Sorensen P. Prevalence and characteristics of dementia in Parkinson disease: An 8-year prospective study. Archives of Neurology 2003a; 60: 387–392
   PubMed Web of Science ®Google Scholar
• Aarsland D, Andersen K, Larsen JP, Lolk A, Nielsen H, Kragh-Sorensen P. Risk of dementia in Parkinson's disease: A community-based, prospective study. Neurology 2001; 56: 730–736
   PubMed Web of Science ®Google Scholar
• Aarsland D, Larsen JP, Cummins JL, Laake K. Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: A community-based study. Archives of Neurology 1999; 56: 595–601
   PubMed Web of Science ®Google Scholar
• Aarsland D, Larsen JP, Tandberg E, Laake K. Predictors of nursing home placement in Parkinson's disease: A population-based, prospective study. Journal of the American Geriatrics Society 2000; 48: 938–942
   PubMed Web of Science ®Google Scholar
• Aarsland D, Litvan I, Salmon D, Galasko D, Wentzel-Larsen T, Larsen JP. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: Comparison with progressive supranuclear palsy and Alzheimer's disease. Journal of Neurology, Neurosurgery & Psychiatry 2003b; 74: 1215–1220
   PubMed Web of Science ®Google Scholar
• Aarsland D, Perry R, Brown A, Larsen JP, Ballard C. Neuropathology of dementia in Parkinson's disease: A prospective, community-based study. Annals of Neurology 2005b; 58: 773–776
   PubMed Web of Science ®Google Scholar
• Aarsland D, Perry R, Larsen JP, McKeith IG, O'Brien JT, Perry EK, et al. Neuroleptic sensitivity in Parkinson's disease and Parkinsonian dementias. Journal of Clinical Psychiatry 2005a; 66: 633–637
   PubMed Web of Science ®Google Scholar
• Apaydin H, Ahlskog JE, Parisi JE, Boeve BF, Dickson DW. Parkinson disease neuropathology: Later-developing dementia and loss of the levodopa response. Archives of Neurology 2002; 59: 102–112
   PubMed Web of Science ®Google Scholar
• Ballard CG, Aarsland D, McKeith I, O'Brien J, Gray A, Cormack F, et al. Fluctuations in attention: PD dementia versus DLB with Parkinsonism. Neurology 2002; 59: 1714–1720
   PubMed Web of Science ®Google Scholar
• Beatty WW. Cognition in a patient with very mild right-sided hemiparkinsonism. Neurocase 2002; 8: 28–39
   PubMed Web of Science ®Google Scholar
• Benito-Leon J, Louis ED, Bermejo-Pareja F. Elderly-onset essential tremor is associated with dementia. Neurology 2006; 66: 1500–1505, Neurological Disorders in Central Spain Study Group
   Google Scholar
• Boeve BF, Silber MH, Parisi JE, Dickson DW, Ferman TJ, Benarroch EE, et al. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or Parkinsonism. Neurology 2003; 61: 40–45
   PubMed Web of Science ®Google Scholar
• Bressan RA, Crippa JA. The role of dopamine in reward and pleasure behaviour–review of data from preclinical research. Acta Psychiatrica Scandinavica, Supplementum 2005; 427: 14–21
   Google Scholar
• Bronnick K, Emre M, Lane R, Tekin S, Aarsland D. Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease. Journal of Neurology Neurosurgery Psychiatry 2007; 78: 1064–1068
   Google Scholar
• Burton EJ, McKeith IG, Burn DJ, Williams ED, O'Brien JT. Cerebral atrophy in Parkinson's disease with and without dementia: A comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 2004; 127: 791–800
   PubMed Web of Science ®Google Scholar
• Cahn-Weiner DA, Grace J, Ott BR, Fernandez HH, Friedman JH. Cognitive and behavioral features discriminate between Alzheimer's and Parkinson's disease. Neuropsychiatry, Neuropsychology, & Behavioral Neurology 2002; 15: 79–87
   PubMedGoogle Scholar
• Camicioli R, Oken BS, Sexton G, Kaye JA, Nutt JG. Verbal fluency task affects gait in Parkinson's disease with motor freezing. Journal of Geriatric Psychiatry & Neurology 1998; 11: 181–185
   PubMed Web of Science ®Google Scholar
• Colloby SJ, Williams ED, Burn DJ, Lloyd JJ, McKeith IG, O'Brien JT. Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT. European Journal of Nuclear Medicine & Molecular Imaging 2005; 32: 1176–1185
   PubMedGoogle Scholar
• Comella CL, Tanner CM, Ristanovic RK. Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations. Annals of Neurology 1993; 34: 710–714
   PubMed Web of Science ®Google Scholar
• Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 1991; 114: 2095–2122
   PubMed Web of Science ®Google Scholar
• Cormack F, Aarsland D, Ballard C, Tovee MJ. Pentagon drawing and neuropsychological performance in Dementia with Lewy bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia. International Journal of Geriatric Psychiatry 2004; 4: 371–377
   Google Scholar
• Costa A, Peppe A, Dell'Agnello G, Carlesimo GA, Murri L, Bonuccelli U, et al. Dopaminergic modulation of visual-spatial working memory in Parkinson's disease. Dementia & Geriatric Cognitive Disorders 2003; 15: 55–66
   PubMed Web of Science ®Google Scholar
• Cummings JL, Darkins A, Mendez M, Hill MA, Benson DF. Alzheimer's disease and Parkinson's disease: Comparison of speech and language alterations. Neurology 1988; 38: 680–684
   PubMed Web of Science ®Google Scholar
• de la Fuente-Fernández R, Nunez MA, Lopez E. The apolipoprotein E epsilon 4 allele increases the risk of drug-induced hallucinations in Parkinson's disease. Clinical Neuropharmacology 1999; 22: 226–230
   PubMed Web of Science ®Google Scholar
• Dujardin K, Defebvre L, Krystkowiak P, Blond S, Destee A. Influence of chronic bilateral stimulation of the subthalamic nucleus on cognitive function in Parkinson's disease. Journal of Neurology 2001; 248: 603–611
   PubMed Web of Science ®Google Scholar
• Emre M, Aarsland D, Albanese A, Byrne EJ, Deuschl G, De Deyn PP, et al. Rivastigmine for dementia associated with Parkinson's disease. New England Journal of Medicine 2004; 351: 2509–2518
   PubMed Web of Science ®Google Scholar
• Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Movement Disorders 2007; 22: 1689–1707
   PubMed Web of Science ®Google Scholar
• Evans AH, Lawrence AD, Potts J, MacGregor L, Katzenschlager R, Shaw K, et al. Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry 2006; 77: 317–321
   PubMed Web of Science ®Google Scholar
• Fama R, Sullivan EV. Motor sequencing in Parkinson's disease: Relationship to executive function and motor rigidity. Cortex 2002; 38: 753–767
   PubMed Web of Science ®Google Scholar
• Fenelon G, Thobois S, Bonnet AM, Broussolle E, Tison F. Tactile hallucinations in Parkinson's disease. Journal of Neurology 2002; 249: 1699–1703
   PubMed Web of Science ®Google Scholar
• Ferini-Strambi L, Di Gioia MR, Castronovo V, Oldani A, Zucconi M, Cappa SF. Neuropsychological assessment in idiopathic REM sleep behavior disorder (RBD): Does the idiopathic form of RBD really exist?. Neurology 2004; 62: 41–45
   PubMed Web of Science ®Google Scholar
• Firbank MJ, Colloby SJ, Burn DJ, McKeith IG, O'Brien JT. Regional cerebral blood flow in Parkinson's disease with and without dementia. Neuroimage 2003; 2: 1309–1319
   Google Scholar
• Freedman M, Rivoira P, Butters N, Sax DS, Feldman RG. Retrograde amnesia in Parkinson's disease. Canadian Journal of Neurological Sciences 1984; 11: 297–301
   PubMed Web of Science ®Google Scholar
• Friedman A, Sienkiewicz J. Psychotic complications of long-term levodopa treatment of Parkinson's disease. Acta Neurologica Scandinavica 1991; 84: 111–113
   Google Scholar
• Fujii C, Harada S, Ohkoshi N, Hayashi A, Yoshizawa K. Cross-cultural traits for personality of patients with Parkinson's disease in Japan. American Journal of Medical Genetics 2000; 96: 1–3
   PubMed Web of Science ®Google Scholar
• Giladi N, Treves TA, Paleacu D, Shabtai H, Orlov Y, Kandinov B, et al. Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease. Journal of Neural Transmission 2000; 107: 59–71
   PubMed Web of Science ®Google Scholar
• Giladi N, Weitzman N, Schreiber S, Shabtai H, Peretz C. New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: The role of dopamine agonist treatment and age at motor symptoms onset. Journal of Psychopharmacology 2007; 21: 501–506
   PubMed Web of Science ®Google Scholar
• Gironell A, Kulisevsky J, Rami L, Fortuny N, Garcia-Sanchez C, Pascual-Sedano B. Effects of pallidotomy and bilateral subthalamic stimulation on cognitive function in Parkinson disease. A controlled comparative study. Journal of Neurology 2003; 250: 917–923
   PubMed Web of Science ®Google Scholar
• Goetz CG, Burke PF, Leurgans S, Berry-Kravis E, Blasucci LM, Raman R, et al. Genetic variation analysis in Parkinson disease patients with and without hallucinations: Case-control study. Archives of Neurology 2001; 58: 209–213
   PubMed Web of Science ®Google Scholar
• Harding AJ, Broe GA, Halliday GM. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 2002; 125: 391–403
   PubMed Web of Science ®Google Scholar
• Hausdorff JM, Balash J, Giladi N. Effects of cognitive challenge on gait variability in patients with Parkinson's disease. Journal of Geriatric Psychiatry & Neurology 2003; 16: 53–58
   PubMed Web of Science ®Google Scholar
• Hausdorff JM, Cudkowicz ME, Firtion R, Wei JY, Goldberger AL. Gait variability and basal ganglia disorders: Stride-to-stride variations of gait cycle timing in Parkinson's disease and Huntington's disease. Movement Disorders 1998; 13: 428–437
   PubMed Web of Science ®Google Scholar
• Hausdorff JM, Doniger GM, Springer S, Yogev G, Simon ES, Giladi N. A common cognitive profile in elderly fallers and in patients with Parkinson's disease: The prominence of impaired executive function and attention. Experimental Aging Research 2006; 32: 411–429
   PubMed Web of Science ®Google Scholar
• Holroyd S, Currie L, Wooten GF. Prospective study of hallucinations and delusions in Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry 2001; 70: 734–738
   PubMed Web of Science ®Google Scholar
• Hubble JP, Venkatesh R, Hassanein RE, Gray C, Koller WC. Personality and depression in Parkinson's disease. Journal of Nervous & Mental Disease 1993; 181: 657–662
   PubMedGoogle Scholar
• Inzelberg R, Bonuccelli U, Schechtman E, Miniowich A, Strugatsky R, Ceravolo R, et al. Association between amantadine and the onset of dementia in Parkinson's disease. Movement Disorders 2006; 21: 1375–1379
   Web of Science ®Google Scholar
• Inzelberg R, Kipervasser S, Korczyn AD. Auditory hallucinations in Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry 1998; 64: 533–535
   PubMed Web of Science ®Google Scholar
• Jasinska-Myga B, Opala G, Goetz CG, Tustanowski J, Ochudlo S, Gorzkowska A, et al. Apolipoprotein E gene polymorphism, total plasma cholesterol level, and Parkinson disease dementia. Archives of Neurology 2007; 64: 261–265
   Google Scholar
• Jimenez-Jimenez FJ, Mateo D, Gimenez-Roldan S. Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: A case-control study. Movement Disorders 1992; 7: 339–344
   PubMed Web of Science ®Google Scholar
• Kleiner-Fisman G, Fisman DN, Zamir O, Dostrovsky JO, Sime E, Saint-Cyr JA, et al. Subthalamic nucleus deep brain stimulation for Parkinson's disease after successful pallidotomy: Clinical and electrophysiological observations. Movement Disorders 2004; 10: 1209–1214
   Google Scholar
• Koller WC, Glatt SL, Hubble JP, Paolo A, Troster AI, Handler MS, et al. Apolipoprotein E genotypes in Parkinson's disease with and without dementia. Annals of Neurology 1995; 37: 242–245
   Google Scholar
• Lang AE, Lozano AM, Montgomery E, Duff J, Tasker R, Hutchinson W. Posteroventral medial pallidotomy in advanced Parkinson's disease. New England Journal of Medicine 1997; 337: 1036–1042
   PubMed Web of Science ®Google Scholar
• Lange KW, Robbins TW, Marsden CD, James M, Owen AM, Paul GM. L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology 1992; 107: 394–404
   PubMed Web of Science ®Google Scholar
• Lemstra AW, Schoenmaker N, Rozemuller-Kwakkel AJ, van Gool WA. The association of neuroleptic sensitivity in Lewy body disease with a false positive clinical diagnosis of Creutzfeldt-Jakob disease. International Journal of Geriatric Psychiatry 2006; 21: 1031–1035
   Google Scholar
• Levy G, Jacobs DM, Tang MX, Cote LJ, Louis ED, Alfaro B, et al. Memory and executive function impairment predict dementia in Parkinson's disease. Movement Disorders 2002; 17: 1221–1226
   PubMed Web of Science ®Google Scholar
• Litvan I, Mohr E, Williams J, Gomez C, Chase TN. Differential memory and executive functions in demented patients with Parkinson's and Alzheimer's disease. Journal of Neurology, Neurosurgery & Psychiatry 1991; 54: 25–29
   PubMed Web of Science ®Google Scholar
• Lombardi WJ, Woolston DJ, Roberts JW, Gross RE. Cognitive deficits in patients with essential tremor. Neurology 2001; 57: 785–790
   PubMed Web of Science ®Google Scholar
• Louis ED, Frucht SJ. Prevalence of essential tremor in patients with Parkinson's disease versus Parkinson-plus syndromes. Movement Disorders 2007; 22: 1402–1407
   Google Scholar
• Louis ED, Honig LS, Vonsattel JP, Maraganore DM, Borden S, Moskowitz. Essential tremor associated with focal nonnigral Lewy bodies: A clinicopathologic study. Archives of Neurology 2005; 62: 1004–1007
   Google Scholar
• Marder K, Tang MX, Cote L, Stern Y, Mayeux R. The frequency and associated risk factors for dementia in patients with Parkinson's disease. Archives of Neurology 1995; 52: 695–701
   PubMed Web of Science ®Google Scholar
• Mattila PM, Rinne JO, Helenius H, Dickson DW, Roytta M. Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease. Acta Neuropathologica 2000; 100: 285–290
   PubMed Web of Science ®Google Scholar
• Mayeux R, Saunders AM, Shea S, Mirra S, Evans D, Roses AD, et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's disease. New England Journal of Medicine 1998; 338: 506–511
   PubMed Web of Science ®Google Scholar
• McKeith I, Del ST, Spano P, Emre M, Wesnes K, Anand R, et al. Efficacy of rivastigmine in dementia with Lewy bodies: A randomised, double-blind, placebo-controlled international study. Lancet 2000; 356: 2031–2036
   PubMed Web of Science ®Google Scholar
• McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology 2005; 65: 1863–1872, Consortium on DLB.
   Google Scholar
• Melamed E, Friedberg G, Zoldan J. Psychosis: Impact on the patient and family. Neurology 1999; 52: S14–16
   PubMed Web of Science ®Google Scholar
• Melton LJ, Leibson CL, Achenbach SJ, Bower JH, Maraganore DM, Oberg AL, et al. Fracture risk after the diagnosis of Parkinson's disease: Influence of concomitant dementia. Movement Disorders 2006; 21: 1361–1367
   PubMed Web of Science ®Google Scholar
• Menza MA, Forman NE, Goldstein HS, Golbe LI. Parkinson's disease, personality, and dopamine. Journal of Neuropsychiatry & Clinical Neurosciences 1990; 2: 282–287
   PubMedGoogle Scholar
• Menza MA, Golbe LI, Cody RA, Forman NE. Dopamine-related personality traits in Parkinson's disease. Neurology 1993; 43: 505–508
   PubMed Web of Science ®Google Scholar
• Merello M, Nouzeilles MI, Cammarota A, Leiguarda R. Effect of memantine (NMDA antagonist) on Parkinson's disease: A double-blind crossover randomized study. Clinical Neuropharmacology 1999; 22: 273–276
   PubMed Web of Science ®Google Scholar
• Merims D, Shabtai H, Korczyn AD, Peretz C, Weizman N, Giladi N. Antiparkinsonian medication is not a risk factor for the development of hallucinations in Parkinson's disease. Journal of Neural Transmission 2004; 111: 1447–1453
   PubMed Web of Science ®Google Scholar
• Molloy SA, Rowan EN, O'Brien JT, McKeith IG, Wesnes K, Burn DJ. Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies. Journal of Neurology, Neurosurgery & Psychiatry 2006; 77: 1323–1328
   PubMed Web of Science ®Google Scholar
• Morgan JC, diDonato CJ, Iyer SS, Jenkins PD, Smith JR, Sethi KD. Self-stimulatory behavior associated with deep brain stimulation in Parkinson's disease. Movement Disorders 2006; 21: 283–285
   Google Scholar
• Mosimann UP, Mather G, Wesnes KA, O'Brien JT, Burn DJ, McKeith IG. Visual perception in Parkinson disease dementia and dementia with Lewy bodies. Neurology 2004; 63: 2091–2096
   PubMed Web of Science ®Google Scholar
• Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 2005; 65: 1239–1245
   PubMed Web of Science ®Google Scholar
• Noe E, Marder K, Bell KL, Jacobs DM, Manly JJ, Stern Y. Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia. Movement Disorders 2004; 1: 60–67
   Google Scholar
• Olanow CW, Watts RL, Koller WC. An algorithm (decision tree) for the management of Parkinson's disease: Treatment guidelines. Neurology 2001; 56: S1–S88
   PubMed Web of Science ®Google Scholar
• Olson EJ, Boeve BF, Silber MH. Rapid eye movement sleep behaviour disorder: Demographic, clinical and laboratory findings in 93 cases. Brain 2000; 123: 331–339
   PubMed Web of Science ®Google Scholar
• Pacchetti C, Manni R, Zangaglia R, Mancini F, Marchioni E, Tassorelli C, et al. Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease. Movement Disorders 2005; 11: 1439–1448
   Google Scholar
• Parsian A, Racette B, Goldsmith LJ, Perlmutter JS. Parkinson's disease and apolipoprotein E: Possible association with dementia but not age at onset. Genomics 2002; 79: 458–461
   PubMedGoogle Scholar
• Paulson GW, Dadmehr N. Is there a premorbid personality typical for Parkinson's disease?. Neurology 1991; 41: 73–76
   PubMedGoogle Scholar
• Pillon B, Ertle S, Deweer B, Sarazin M, Agid Y, Dubois B. Memory for spatial location is affected in Parkinson's disease. Neuropsychologia 1996; 34: 77–85
   Google Scholar
• Poewe W, Gerstenbrand F, Ransmayr G, Plörer S. Premorbid personality of Parkinson patients. Journal of Neural Transmission, Supplementum 1983; 19: 215–224
   Google Scholar
• Pontone G, Williams JR, Bassett SS, Marsh L. Clinical features associated with impulse control disorders in Parkinson disease. Neurology 2006; 67: 1258–1261
   PubMed Web of Science ®Google Scholar
• Rocca WA, Bower JH, Ahlskog JE, Elbaz A, Grossardt BR, McDonnell SK, et al. Risk of cognitive impairment or dementia in relatives of patients with Parkinson disease. Archives of Neurology 2007; 64: 1458–1464
   Google Scholar
• Sanchez-Ramos JR, Ortoll R, Paulson GW. Visual hallucinations associated with Parkinson disease. Archives of Neurology 1996; 53: 1265–1268
   PubMed Web of Science ®Google Scholar
• Schrag A, Ben-Shlomo Y, Brown R, Marsden CD, Quinn N. Young-onset Parkinson's disease revisited–Clinical features, natural history, and mortality. Movement Disorders 1998; 13: 885–894
   PubMed Web of Science ®Google Scholar
• Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease?. Journal of Neurology, Neurosurgery & Psychiatry 2000; 69: 308–312
   PubMed Web of Science ®Google Scholar
• Shahed J, Jankovic J. Exploring the relationship between essential tremor and Parkinson's disease. Parkinsonism & Related Disorders 2007; 13: 67–76
   PubMed Web of Science ®Google Scholar
• Smeding HM, Speelman JD, Koning-Haanstra M, Schuurman PR, Nijssen P, van LT, et al. Neuropsychological effects of bilateral STN stimulation in Parkinson disease: A controlled study. Neurology 2006; 66: 1830–1836
   PubMed Web of Science ®Google Scholar
• Starkstein SE, Bolduc PL, Mayberg HS, Preziosi TJ, Robinson RG. Cognitive impairments and depression in Parkinson's disease: A follow up study. Journal of Neurology, Neurosurgery & Psychiatry 1990; 53: 597–602
   PubMed Web of Science ®Google Scholar
• Starkstein SE, Mayberg HS, Leiguarda R, Preziosi TJ, Robinson RG. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry 1992; 55: 377–382
   PubMed Web of Science ®Google Scholar
• Starkstein SE, Petracca G, Chemerinski E, Teson A, Sabe L, Merello M, et al. Depression in classic versus akinetic-rigid Parkinson's disease. Movement Disorders 1998; 13: 29–33
   PubMed Web of Science ®Google Scholar
• Szarfman A, Doraiswamy PM, Tonning JM, Levine JG. Association between pathologic gambling and Parkinsonian therapy as detected in the Food and Drug Administration Adverse Event database. Archives of Neurology 2006; 63: 299–300
   Google Scholar
• Tandberg E, Larsen JP, Aarsland D, Cummings JL. The occurrence of depression in Parkinson's disease. A community-based study. Archives of Neurology 1996; 53: 175–179
   PubMed Web of Science ®Google Scholar
• Troster AI, Paolo AM, Lyons KE, Glatt SL, Hubble JP, Koller WC. The influence of depression on cognition in Parkinson's disease: A pattern of impairment distinguishable from Alzheimer's disease. Neurology 1995a; 45: 672–676
   PubMed Web of Science ®Google Scholar
• Troster AI, Stalp LD, Paolo AM, Fields JA, Koller WC. Neuropsychological impairment in Parkinson's disease with and without depression. Archives of Neurology 1995b; 52: 1164–1169
   PubMed Web of Science ®Google Scholar
• Van Spaendonck KP, Berger HJ, Horstink MW, Buytenhuijs EL, Cools AR. Executive functions and disease characteristics in Parkinson's disease. Neuropsychologia 1996; 34: 617–626
   PubMed Web of Science ®Google Scholar
• Vendette M, Gagnon JF, Decary A, Massicotte-Marquez J, Postuma RB, Doyon J, et al. REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia. Neurology 2007; 69: 1843–1849
   PubMed Web of Science ®Google Scholar
• Wakabayashi K, Kakita A, Hayashi S, Okuizumi K, Onodera O, Tanaka H, et al. Apolipoprotein E epsilon4 allele and progression of cortical Lewy body pathology in Parkinson's disease. Acta Neuropathologica 1998; 95: 450–454
   Google Scholar
• Wilson RS, Kaszniak AW, Klawans HL, Garron DC. High speed memory scanning in Parkinsonism. Cortex 1980; 16: 67–72
   PubMed Web of Science ®Google Scholar
• Witjas T, Kaphan E, Azulay JP, Blin O, Ceccaldi M, Pouget J, et al. Nonmotor fluctuations in Parkinson's disease: Frequent and disabling. Neurology 2002; 59: 408–413
   PubMed Web of Science ®Google Scholar
• York MK, Dulay M, Macias A, Levin HS, Grossman R, Simpson R, Jankovic J. Cognitive declines following bilateral subthalamic nucleus deep brain stimulation for the treatment of Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry 2008; 79: 789–795
   PubMed Web of Science ®Google Scholar